The letter calls for the federal government to probe the marketing of opioids in Canada and to “directly compensate victims of the opioid crisis with funds recovered from opioid manufacturers with new legislation.” “Similar legislation is in place for tobacco companies and the victims of their inappropriate marketing practices,” the letter adds. In Canada, victims have pursued a civil suit, and the company has a proposed settlement for $20 million with $2 million going to the provinces and territories. “This complex public health issue is a matter of deep concern to Purdue Pharma (Canada),” the statement added. Purdue Pharma (Canada) has made no admissions of liability,” the company’s statement added. February’s federal budget earmarked $231 million for dealing with the opioid crisis, including improving access to treatment.

Source: thestar April 21, 2018 23:15 UTC